NCT04673227 is a clinical trial of Blood draw in LTBI, sponsored by Thomayer University Hospital.

Who is sponsoring NCT04673227?

NCT04673227 is sponsored by Thomayer University Hospital.

What drugs are being tested in NCT04673227?

Interventions in NCT04673227: Blood draw.

What condition does NCT04673227 study?

NCT04673227 studies LTBI, BCG Vaccination Reaction, TB.

Is NCT04673227 still recruiting?

NCT04673227 is currently status unknown. Last updated 17 December 2020.

Last reviewed 2020-12-17 · How we verify

NCT04673227

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI)

Status unknown Last updated 17 December 2020

What this trial tests

trial testing Blood draw in LTBI in 120 participants. Status unknown.

Timeline

2 January 2020

Primary endpoint
26 May 2020

26 December 2022

Quick facts

Lead sponsor	Thomayer University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	120
Start date	2 January 2020
Primary completion	26 May 2020
Estimated completion	26 December 2022
Sites	2 locations across Czechia

Drugs / interventions tested

Blood draw — full drug profile →

Conditions studied

LTBI — all drugs for LTBI →
BCG Vaccination Reaction — all drugs for BCG Vaccination Reaction →
TB — all drugs for TB →

Sponsor

Thomayer University Hospital

Who can join

Adults 4 to 70, any sex, with LTBI or BCG Vaccination Reaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

TB-reactive immune cells will be tested in a multiparametric flow cytometry to distinguish an immune response for antigens of Mycobacterium spp. in TB disease/latent infection or a reaction after BCG vaccine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood draw

Trials testing the same drug.

NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
NCT07252622 — Progesterone Levels and Frozen Embryo Transfer Outcomes · not yet recruiting
NCT07382076 — Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population · active not recruiting
NCT06011824 — A Study of Effect of Megakaryocytes and Platelets in Breast Cancer · completed
NCT05912400 — Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1 · completed

Other Thomayer University Hospital trials

Trials by the same sponsor.

NCT04899869 — Faecal Microbiota Transplantation in Irritable Bowel Syndrome · NA · completed
NCT05178277 — Czech AATD Registry · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04673227 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Thomayer University Hospital
Last refreshed: 17 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04673227.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing